• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

HIC1与FOXP3多蛋白复合物相互作用:调节人类调节性T细胞分化和功能的新型多效性机制。

HIC1 interacts with FOXP3 multi protein complex: Novel pleiotropic mechanisms to regulate human regulatory T cell differentiation and function.

作者信息

Andrabi Syed Bilal Ahmad, Batkulwar Kedar, Bhosale Santosh D, Moulder Robert, Khan Meraj Hasan, Buchacher Tanja, Khan Mohd Moin, Arnkil Ilona, Rasool Omid, Marson Alexander, Kalim Ubaid Ullah, Lahesmaa Riitta

机构信息

Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku 20520, Finland; InFLAMES Research Flagship Center, University of Turku.

Turku Bioscience Centre, University of Turku and Åbo Akademi University, Turku 20520, Finland; Precision Biomarker Laboratories, Cedars-Sinai Medical Center, Los Angeles, CA 90048, USA.

出版信息

Immunol Lett. 2023 Nov;263:123-132. doi: 10.1016/j.imlet.2023.09.001. Epub 2023 Oct 12.

DOI:10.1016/j.imlet.2023.09.001
PMID:37838026
Abstract

Transcriptional repressor, hypermethylated in cancer 1 (HIC1) participates in a range of important biological processes, such as tumor repression, immune suppression, embryonic development and epigenetic gene regulation. Further to these, we previously demonstrated that HIC1 provides a significant contribution to the function and development of regulatory T (Treg) cells. However, the mechanism by which it regulates these processes was not apparent. To address this question, we used affinity-purification mass spectrometry to characterize the HIC1 interactome in human Treg cells. Altogether 61 high-confidence interactors were identified, including IKZF3, which is a key transcription factor in the development of Treg cells. The biological processes associated with these interacting proteins include protein transport, mRNA processing, non-coding (ncRNA) transcription and RNA metabolism. The results revealed that HIC1 is part of a FOXP3-RUNX1-CBFB protein complex that regulates Treg signature genes thus improving our understanding of HIC1 function during early Treg cell differentiation.

摘要

癌症中高甲基化的转录抑制因子1(HIC1)参与一系列重要的生物学过程,如肿瘤抑制、免疫抑制、胚胎发育和表观遗传基因调控。除此之外,我们之前证明HIC1对调节性T(Treg)细胞的功能和发育有重大贡献。然而,其调节这些过程的机制尚不清楚。为了解决这个问题,我们使用亲和纯化质谱法来表征人Treg细胞中的HIC1相互作用组。共鉴定出61个高可信度的相互作用蛋白,包括IKZF3,它是Treg细胞发育中的关键转录因子。与这些相互作用蛋白相关的生物学过程包括蛋白质转运、mRNA加工、非编码(ncRNA)转录和RNA代谢。结果表明,HIC1是FOXP3-RUNX1-CBFB蛋白复合物的一部分,该复合物调节Treg特征基因,从而增进了我们对HIC1在早期Treg细胞分化过程中功能的理解。

相似文献

1
HIC1 interacts with FOXP3 multi protein complex: Novel pleiotropic mechanisms to regulate human regulatory T cell differentiation and function.HIC1与FOXP3多蛋白复合物相互作用:调节人类调节性T细胞分化和功能的新型多效性机制。
Immunol Lett. 2023 Nov;263:123-132. doi: 10.1016/j.imlet.2023.09.001. Epub 2023 Oct 12.
2
Transcriptional Repressor HIC1 Contributes to Suppressive Function of Human Induced Regulatory T Cells.转录抑制因子 HIC1 有助于人诱导调节性 T 细胞的抑制功能。
Cell Rep. 2018 Feb 20;22(8):2094-2106. doi: 10.1016/j.celrep.2018.01.070.
3
Control of regulatory T-cell differentiation and function by T-cell receptor signalling and Foxp3 transcription factor complexes.调控性 T 细胞分化和功能的 T 细胞受体信号和 Foxp3 转录因子复合物。
Immunology. 2020 May;160(1):24-37. doi: 10.1111/imm.13178. Epub 2020 Mar 9.
4
HIC1 epigenetically represses CIITA transcription in B lymphocytes.HIC1在B淋巴细胞中通过表观遗传方式抑制CIITA转录。
Biochim Biophys Acta. 2016 Dec;1859(12):1481-1489. doi: 10.1016/j.bbagrm.2016.10.003. Epub 2016 Oct 6.
5
Hypermethylated in cancer 1 (HIC1) recruits polycomb repressive complex 2 (PRC2) to a subset of its target genes through interaction with human polycomb-like (hPCL) proteins.抑癌基因 1 高甲基化(HIC1)通过与人类多梳样蛋白(hPCL)蛋白相互作用,将多梳抑制复合物 2(PRC2)募集到其靶基因的一部分。
J Biol Chem. 2012 Mar 23;287(13):10509-10524. doi: 10.1074/jbc.M111.320234. Epub 2012 Feb 7.
6
From stability to dynamics: understanding molecular mechanisms of regulatory T cells through Foxp3 transcriptional dynamics.从稳定性到动态性:通过 Foxp3 转录动态理解调节性 T 细胞的分子机制。
Clin Exp Immunol. 2019 Jul;197(1):14-23. doi: 10.1111/cei.13194. Epub 2018 Sep 17.
7
Induction of CD4CD25Foxp3 regulatory T cells by mesenchymal stem cells is associated with RUNX complex factors.间充质干细胞诱导 CD4CD25Foxp3 调节性 T 细胞与 RUNX 复合物因子有关。
Immunol Res. 2018 Feb;66(1):207-218. doi: 10.1007/s12026-017-8973-4.
8
Recruitment of Histone Methyltransferase Ehmt1 to Foxp3 TSDR Counteracts Differentiation of Induced Regulatory T Cells.招募组蛋白甲基转移酶 Ehmt1 到 Foxp3 TSDR 可拮抗诱导的调节性 T 细胞的分化。
J Mol Biol. 2019 Sep 6;431(19):3606-3625. doi: 10.1016/j.jmb.2019.07.031. Epub 2019 Jul 27.
9
HIC1 tumour suppressor gene is suppressed in acute myeloid leukaemia and induced during granulocytic differentiation.HIC1肿瘤抑制基因在急性髓系白血病中受到抑制,并在粒细胞分化过程中被诱导表达。
Br J Haematol. 2008 Apr;141(2):179-87. doi: 10.1111/j.1365-2141.2008.06992.x. Epub 2008 Mar 3.
10
Histone methylation mediates plasticity of human FOXP3(+) regulatory T cells by modulating signature gene expressions.组蛋白甲基化通过调节特征基因表达来介导人 FOXP3(+)调节性 T 细胞的可塑性。
Immunology. 2014 Mar;141(3):362-76. doi: 10.1111/imm.12198.

引用本文的文献

1
Tumor-derived colorectal cancer organoids induce a unique Treg cell population by directing CD4 T cell differentiation.肿瘤来源的结直肠癌类器官通过引导CD4 T细胞分化诱导出独特的调节性T细胞群体。
iScience. 2025 Jan 17;28(2):111827. doi: 10.1016/j.isci.2025.111827. eCollection 2025 Feb 21.
2
Phenotypic profiling of human induced regulatory T cells at early differentiation: insights into distinct immunosuppressive potential.人诱导调节性 T 细胞早期分化的表型分析:对不同免疫抑制潜能的深入了解。
Cell Mol Life Sci. 2024 Sep 12;81(1):399. doi: 10.1007/s00018-024-05429-3.
3
Long noncoding RNA LIRIL2R modulates FOXP3 levels and suppressive function of human CD4 regulatory T cells by regulating IL2RA.
长非编码 RNA LIRIL2R 通过调节 IL2RA 来调节 FOXP3 水平和人 CD4 调节性 T 细胞的抑制功能。
Proc Natl Acad Sci U S A. 2024 Jun 4;121(23):e2315363121. doi: 10.1073/pnas.2315363121. Epub 2024 May 28.